Open access
Oct 2026
Real‐world clinical, biomarker, and imaging outcomes of lecanemab in Alzheimer's disease: a multicenter longitudinal cohort study in Jiangsu, China
Abstract INTRODUCTION Real‐world data on lecanemab's efficacy and the longitudinal dynamics of plasma biomarkers are scarce in Chinese patients with Alzheimer's disease (AD). METHODS In this multicenter cohort study, 181 AD patients received biweekly lecanemab. Disease‐stage‐specific Clinical Dementia Rating–Sum of Box...
Limoran Tang, Xi-Chen Chen, Li Zhang et al.
· Alzheimer's & Dementia · 0 citations